Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Molinari

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Tumori|May 24, 2014
Circulating free DNA in a screening program for early colorectal cancer detectionFederica Perrone, Andrea Lampis, Claudia Bertan, et al.
Plos One|October 7, 2009
Multi-determinants analysis of molecular alterations for predicting clinical benefit to EGFR-targeted monoclonal antibodies in colorectal cancerAndrea Sartore-Bianchi, Federica Di Nicolantonio, Michele Nichelatti, et al.
Cells|June 2, 2021
SIRT5 Inhibition Induces Brown Fat-Like Phenotype in 3T3-L1 PreadipocytesFrancesca Molinari, Alessandra Feraco, Simone Mirabilii, et al.
Human Mutation|January 2, 2009
IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumorsFonnet E Bleeker, Simona Lamba, Sieger Leenstra, et al.
Virchows Archiv : an International Journal of Pathology|March 5, 2014
APC alterations are frequently involved in the pathogenesis of acinar cell carcinoma of the pancreas, mainly through gene loss and promoter hypermethylationDaniela Furlan, Nora Sahnane, Barbara Bernasconi, et al.
Virchows Archiv : an International Journal of Pathology|November 21, 2015
TP53 alterations in pancreatic acinar cell carcinoma: new insights into the molecular pathology of this rare cancerStefano La Rosa, Barbara Bernasconi, Milo Frattini, et al.
Plos One|June 24, 2021
A new sensitive and fast assay for the detection of EGFR mutations in liquid biopsiesSteffen Grann Jensen, Samantha Epistolio, Cesilie Lind Madsen, et al.
The Journal of Clinical Investigation|July 29, 2010
Deregulation of the PI3K and KRAS signaling pathways in human cancer cells determines their response to everolimusFederica Di Nicolantonio, Sabrina Arena, Josep Tabernero, et al.
Frontiers in Oncology|July 15, 2022
A Pilot, Prospective, Observational Study to Investigate the Value of NGS in Liquid Biopsies to Predict Tumor Response After Neoadjuvant Chemo-Radiotherapy in Patients With Locally Advanced Rectal Cancer: The LiBReCa StudyRaffaello Roesel, Samantha Epistolio, Francesca Molinari, et al.
Genes, Chromosomes & Cancer|August 29, 2012
Aberrant promoter methylation of beta-1,4 galactosyltransferase 1 as potential cancer-specific biomarker of colorectal tumorsMaria Luana Poeta, Emanuela Massi, Paola Parrella, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Tumori|May 24, 2014
Circulating free DNA in a screening program for early colorectal cancer detectionFederica Perrone, Andrea Lampis, Claudia Bertan, et al.
Plos One|October 7, 2009
Multi-determinants analysis of molecular alterations for predicting clinical benefit to EGFR-targeted monoclonal antibodies in colorectal cancerAndrea Sartore-Bianchi, Federica Di Nicolantonio, Michele Nichelatti, et al.
Cells|June 2, 2021
SIRT5 Inhibition Induces Brown Fat-Like Phenotype in 3T3-L1 PreadipocytesFrancesca Molinari, Alessandra Feraco, Simone Mirabilii, et al.
Human Mutation|January 2, 2009
IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumorsFonnet E Bleeker, Simona Lamba, Sieger Leenstra, et al.
Virchows Archiv : an International Journal of Pathology|March 5, 2014
APC alterations are frequently involved in the pathogenesis of acinar cell carcinoma of the pancreas, mainly through gene loss and promoter hypermethylationDaniela Furlan, Nora Sahnane, Barbara Bernasconi, et al.
Virchows Archiv : an International Journal of Pathology|November 21, 2015
TP53 alterations in pancreatic acinar cell carcinoma: new insights into the molecular pathology of this rare cancerStefano La Rosa, Barbara Bernasconi, Milo Frattini, et al.
Plos One|June 24, 2021
A new sensitive and fast assay for the detection of EGFR mutations in liquid biopsiesSteffen Grann Jensen, Samantha Epistolio, Cesilie Lind Madsen, et al.
The Journal of Clinical Investigation|July 29, 2010
Deregulation of the PI3K and KRAS signaling pathways in human cancer cells determines their response to everolimusFederica Di Nicolantonio, Sabrina Arena, Josep Tabernero, et al.
Frontiers in Oncology|July 15, 2022
A Pilot, Prospective, Observational Study to Investigate the Value of NGS in Liquid Biopsies to Predict Tumor Response After Neoadjuvant Chemo-Radiotherapy in Patients With Locally Advanced Rectal Cancer: The LiBReCa StudyRaffaello Roesel, Samantha Epistolio, Francesca Molinari, et al.
Genes, Chromosomes & Cancer|August 29, 2012
Aberrant promoter methylation of beta-1,4 galactosyltransferase 1 as potential cancer-specific biomarker of colorectal tumorsMaria Luana Poeta, Emanuela Massi, Paola Parrella, et al.
Pageof 6